# Ocular myasthenia gravis management

**Authors:** Mark J. Kupersmith, Gil I. Wolfe, Henry Kaminski

PMC · DOI: 10.3389/fneur.2025.1678151 · Frontiers in Neurology · 2025-11-03

## TL;DR

This paper offers guidance for diagnosing and managing ocular myasthenia gravis, aiming to reduce misdiagnoses and improve treatment.

## Contribution

The paper provides novel clinical recommendations based on the authors' experience and existing literature.

## Key findings

- There is currently no consensus on diagnostic criteria for ocular myasthenia gravis.
- The authors propose practical guidelines for clinicians based on their experience and literature review.

## Abstract

Ocular myasthenia gravis (OMG) has no agreed-upon diagnostic and management criteria, leading to misdiagnoses and often misguided treatments. The purpose of this minireview is to provide guidance to clinicians who encounter possible OMG patients. We cite relevant literature and the recommendations for diagnosis and therapy based on the authors’ extensive experience in OMG. This report provides sound recommendations based on the authors’ successes and failures, coupled with relevant literature in the myasthenia gravis field.

## Linked entities

- **Diseases:** myasthenia gravis (MONDO:0009688)

## Full-text entities

- **Diseases:** OMG (MESH:D009157)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12620256/full.md

## References

65 references — full list in the complete paper: https://tomesphere.com/paper/PMC12620256/full.md

---
Source: https://tomesphere.com/paper/PMC12620256